Background. The goal of “treat-to-target” strategy (T2T) in psoriatic arthritis (PsA) is attaining remission or minimal disease activity (MDA). benefits T2T are shown recently the study TICOPA and REMARCA. But prognostic factors for achievement MDA PsA patients (pts) at early-stage hasn’t been studied yet. Objective – to determine associated with within 12 months (mo) treatment according early ...

Background Fatigue in SLE has a multifactorial origin and disease activity seems to contribute only minimally its genesis. Therefore, non-pharmacological therapeutic strategies should also be considered the management of fatigue. There is some evidence on effectiveness aerobic exercise programs improving fatigue, without negative impact manifestations. Objectives aim this study was analyze fati...

Background The IL-23p19-subunit inhibitor guselkumab (GUS) demonstrated clinically meaningful improvements in fatigue through one year of treatment [1] independent its effects on American College Rheumatology 20% (ACR20) improvement criteria and Minimal Disease Activity (MDA) achievement [2] . Objectives In this post-hoc analysis, the Functional Assessment Chronic Illness Therapy – Fatigue (FAC...